Acamprosate Completed Phase 3 Trials for Fragile X Syndrome (FXS) / Autism Spectrum Conditions/Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01300923Acamprosate in Youth With Fragile X Syndrome